Home / News
Mission updates
Track strategic developments and technical progress from across the Axplora network. These include corporate announcements, expert insights, expansion news and industry updates.
Press Release
September 29, 2026
Axplora launching “Axotecan” to strengthen Global ADC supply
Independent European source of exatecan will expand choice and strengthen supply resilience for ADC developers Gram-scale material available, with validation batches targeted by the end of 2026 and GMP supply planned for late 2027 Cross-business collaboration combines Farmabios’ HPAPI expertise with Novasep CDMO’s integrated ADC capabilities September 29th, 2026 – Axplora, a global manufacturing […]
News
September 25, 2026
Axplora celebrates 60 years of innovation at Chasse-sur-Rhône
More than 300 employees, family members and guests joined the anniversary celebration on Saturday 19 September. Event honors six decades of expertise and the site’s continuing commitment to reliable, responsible manufacturing for customers and patients September 25, 2026 – Axplora, a global CDMO partner for complex small molecules and antibody-drug conjugates (ADCs), has marked 60 […]
News
August 05, 2026
Axplora’s sustainability strategy substantiated by SBTi as company accelerates action across its manufacturing network
Science Based Targets initiative (SBTi) validation provides independent confirmation of Axplora’s emissions-reduction targets. Targets reinforce Axplora’s commitment to helping customers build responsible, transparent and resilient pharmaceutical supply chains. Axplora’s ActNow 2030 initiative commits to reducing Scope 1 and 2 emissions by 42% and Scope 3 emissions by 25% by 2030. July 2026 – Axplora, a […]
News
July 09, 2026
Axplora’s European CDMO network raises the bar with enhanced EcoVadis ratings across four manufacturing sites
Axplora’s Leverkusen site was awarded Platinum, with Le Mans receiving Gold, and Pompey and Chasse-sur-Rhône Silver in their first individual EcoVadis assessments. Recognition reinforces Axplora’s commitment to helping customers navigate increasingly complex supply chains with confidence through responsible, transparent and reliable manufacturing. 9 July, 2026 – Axplora, a global CDMO Partner for complex […]
News
June 10, 2026
Axplora consolidates UDCA manufacturing at Vizag site to strengthen integrated global supply and support future growth
Move reinforces Axplora’s integrated API supply model, expands critical manufacturing capabilities in India and enables Farmabios to sharpen focus on Steroids and HPAPI leadership June 10th, 2026 – Axplora, a global leader in the manufacturing of small molecule APIs and ADCs for the pharmaceutical industry, today announced the strategic consolidation of ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the PharmaZell business unit. Production will transition fully from the […]
News
March 17, 2026
Biopharma’s Growing Emphasis on Highly Potent Drugs Drives Axplora Manufacturing Expansion
Highly potent drugs now account for over 30% of the global pipeline, with more than 1,000 molecules in development — Axplora’s investments in HPAPI capacity help customers bring these complex therapies to market faster $60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy New […]
News
March 17, 2026
Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site
Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site 18 February, 2026 – Axplora, a global CDMO Partner for complex small molecules and antibody-drug conjugates (ADCs), today announced a multi-million-euro investment to expand lyophilization (freeze-drying) capabilities at its Le Mans, France Site strengthening its ability to deliver […]
News
August 05, 2025
Axplora Announces €6.5 Million Investment at Vizag Site and FDA Inspection Success Across Indian Operations
5 August 2025 Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production capacity and reinforce supply chain resilience. This announcement follows the successful completion of routine USFDA inspections in 2025 at both of Axplora’s Indian manufacturing sites, Vizag and Chennai, which form part of […]
News
November 29, 2023
CPHI worldwide 2023 continuity: Interview with Arul Ramadurai, CCO
Discover Arul Ramadurai’s exclusive interview at CPHI worldwide 2023 and learn more about Axplora’s business vision! He talks about patients' security, sites’ audits and certifications, but also about Axplora’s Environmental, Social, and Governance (ESG) strategy and electrochemistry (...). As an emotion is worth a thousand words, we encourage you to enjoy the video!
News
November 21, 2023
CPHI 2023: Interview with Dr. Sylke Hassel, CEO
Discover the exclusive interview with Axplora's CEO, Sylke Hassel at CPHI Worldwide 2023. In this in-depth discussion, Sylke highlights the recent appointments of Stephan Haitz and Pere Paton Morales, key players in Axplora's journey towards innovation and growth.
Partner with us today
Clear your path to launch. Contact our technical experts to manage project complexities and secure your route to market.